SABCS 2022 Meeting News Preview - 3

3
*As of October 25, 2022 | **All times are CENTRAL Time
SABCS 2022 SCHEDULE-AT-A-GLANCE
TUESDAY, DECEMBER 6
8:00 am - 9:45 am
Clinical Research Workshop
Stars at Night Ballroom 1&2
Moderator: Aditya Bardia, MD,
MPH
* Use of the postneoadjuvant
setting to accelerate drug
development
Melinda Telli, MD
* How to measure and
improve drug adherence in
clinical trials
Dawn L. Hershman, MD, MS
* Statistical considerations
for precision medicine
Nabihah Tayob, PhD
* Bringing trials to all patients:
A patient's perspective
Thelma
Perry Brown, BSc
Basic Science Workshop
Stars at Night Ballroom 3&4
Moderator: Alana L. Welm, PhD
* APOBEC and genome evolution
in mBC
Reuben S. Harris, PhD
* Therapy-induced senescence:
Friend or foe?
Sheila Stewart, PhD
* Drug-tolerant persister cells
in cancer
Joan S. Brugge, PhD
* Clinical implications of
tumor heterogeneity single
cell genomics
Nnennaya Kanu, PhD
10:00 am - 12:00 pm
EDUCATIONAL SESSION
BLOCK #1A
Living with Metastatic Breast
Cancer
Stars at Night Ballroom 3&4
Moderator: Anne Blaes, MD, MSc
* Early palliative care
Tara L. Kaufmann, MD, MSCE
* Support for patients with MBC
Abbey Kaler, NP
* Financial Toxicity
Fumiko Chino, MD
* Patient Perspective
Christine Hodgdon, MS;
Stephanie Walker, BSN
EDUCATIONAL SESSION
BLOCK #1B
Local Therapy - Best Breast
Practice
Hemisfair Ballroom 1&2
Moderator: Peter Dubsky, MD,
PhD
* Contralateral mastectomy
in patients with germline
mutations
Katharine A. Yao, MD
* RT: How short can it be
David Krug, Dr Med
* How to reconcile novel
reconstructive techniques
with the need to radiate
Christine Solbach, MD, PhD
EDUCATIONAL SESSION
BLOCK #1C
New Agents Targeting HRD in
Breast Cancer
Hemisfair Ballroom 3
Moderator: Erica StringerReasor,
MD
* Pol-theta inhibitors in HRD
tumors
Alan D. d'Andrea, MD
* Mechanisms of sensitivity
and resistance to HRD
targeting agents in breast
cancer - PARPi and beyond
Christopher Lord, DPhil
* ATR inhibitors and PARP1
selective PARP inhibitors
Andrew Tutt, MB ChB, PhD
EDUCATIONAL SESSION
BLOCK #1D
Predictive Value of Treatment
Response and Residual Disease
After Neoadjuvant Therapy
Stars at Night Ballroom 1&2
Moderator: Virginia G.
Kaklamani, MD
* ER therapies
Cynthia X. Ma, MD, PhD
* HER2
Luca Gianni, MD
* Triple Negative
Peter Schmid, MD, PhD,
FRCP
12:00 pm - 2:00 pm
SPECIAL SESSION #1
Big Data and Health Equity
Stars at Night Ballroom 1&2
Moderators: Thelma Brown,
BSc; Maimah Karmo, BS; Charles
Perou, PhD; Patty Spears, BS
Keynote Speakers: Martin
Mendoza, PhD; Barbara
Seggara, D.H.Sc
Panelists: Rhea Blakey; Michael
Crawford, MBA, MHLA; Erika
Hamilton, MD; Martin Mendoza,
PhD; Charlotte Owens, MD;
Barbara Seggara, D.H.Sc;
Jasmine Souers, BSc
SPECIAL SESSION #2
Tackling the Big Questions in
Breast Cancer?
Hall 3
Chairs: Carlos Arteaga, MD;
Angela DeMichele, MD, MSCE
Panelists: Christine
Ambrosone, PhD; Fabrice
André, MD, PhD; Regina
Barzilay, PhD; Joan S. Brugge,
PhD; Matthew J. Ellis, MD, PhD;
Nadia Harbeck, MD, PhD; Yeon
Hee Park, MD, PhD; Lori Pierce,
MD; Patty Spears, BS; Eric
Winer, MD
2:00 pm - 5:00 pm
GENERAL SESSION #1
Hall 3
5:00 pm - 6:15 pm
POSTER SESSION #1
Hall 1
SPOTLIGHT POSTER
DISCUSSION SESSION #1
Racial Outcomes and
Disparities
Hemisfair Ballroom 1&2
SPOTLIGHT POSTER
DISCUSSION SESSION #2
Tumor Immunology and Novel
Immune Therapy Strategies
Stars at Night Ballroom 1&2
SPOTLIGHT POSTER
DISCUSSION SESSION #3
New Radiation Techniques
Stars at Night Ballroom 3&4
7:00 pm - 10:00 pm
OPEN SATELLITE EVENTS
Marriott Rivercenter
WEDNESDAY, DECEMBER 7
7:00 am - 8:15 am
POSTER SESSION #2
Hall 1
SPOTLIGHT POSTER
DISCUSSION SESSION #4
Single Cell Approaches for
Translational Research and
Biomarker Discovery
Hemisfair Ballroom 1&2
SPOTLIGHT POSTER
DISCUSSION SESSION #5
Advances in TNBC Biology
Stars at Night Ballroom 3&4
SPOTLIGHT POSTER
DISCUSSION SESSION #6
Special Populations: Male
Breast Cancer/Geriatrics
Stars at Night Ballroom 3&4
8:30 am - 9:00 am
WILLIAM L. MCGUIRE
MEMORIAL LECTURE
Hall 3
Jeffrey Rosen, PhD
9:00 am - 9:45 am
GENERAL SESSION #2
Hall 3
9:45 am - 11:00 am
HER2 Low: A Separate Entity
Special Session
Hall 3
Chairs: Adam Brufsky, MD, PhD;
Kalliopi Siziopikou, MD, PhD
10:00 am - 5:00 pm
EXHIBITS
Hall 2
11:00 am - 12:00 pm
MINI-SYMPOSIUM #1
C. Kent Osborne HER2 and
ER Crosstalk: Signaling
Mechanisms and Clinical
Implications Symposium
Hall 3
Moderators: Carlos Arteaga,
MD; Virginia G. Kaklamani, MD
Special Guest: C. Kent
Osborne, MD
* HER2 signaling the ER cistrome
Rinath
Jeselsohn, MD
* Oncogene signal transduction
and antiestrogen
resistance
Rachel Schiff, PhD
* Treatment of ER+/HER2+
breast cancer
Stephen Johnston, MBBS
12:00 pm - 12:30 pm
PLENARY LECTURE #1
Hall 3
* Lineage-defined Metabolism
of Normal Mammary Cells
and Origins of Cancer Metabolic
Rama
Khokha, PhD
12:30 pm - 1:00 pm
AACR DISTINGUISHED
LECTURESHIP IN BREAST
CANCER RESEARCH
Hall 3
12:30 pm - 1:30 pm
CAREER DEVELOPMENT
FORUM
Room 304
1:00 pm - 2:00 pm
CLINICAL CASE DISCUSSION
SESSION
Stars at Night Ballroom 1&2
Moderator: Mothaffar Rimawi,
MD
Panelists: Michael Gnant, MD,
FACS, FEBShon; Celina Kleer,
MD; Julia Maues; George Sledge,
Jr, MD; Jonathan Strauss, MD
FORUM #1
Molecular Aspects of DCIS
Progression
Stars at Night Ballroom 3&4
Moderator: E. Shelley Hwang,
MD, MPH
* Tumor stroma in DCIS progression
Robert
West, MD, PhD
* Clonal evolution of DCIS to
invasion
Jelle Wesseling, MD, PhD
* Defining clinical risk: How do
we tailor therapy
Kimberly J. Van Zee, MS,
MD, FACS
2:00 pm - 3:00 pm
CLINICAL CONTROVERSIES
Hall 3
Moderator: Lisa Carey, MD,
ScM, FASCO
* To clip or not to clip
Abigail Caudle, MD; Viviana
E. Galimberti, MD, MPH
* Duration of endocrine
therapy
Kathryn Ruddy, MD,
PhD; Eleftherios (Terry)
Mamounas, MD, MSc
* Post Neoadjuvant therapy in
TNBC
Heather McArthur, MD,
MPH; Susan Domchek, MD
PREVIEW EDITION | SABCSMEETINGNEWS . ORG
2:00 pm - 3:00 pm
MINI-SYMPOSIUM #2
Late Recurrence and Tumor
Dormancy
Stars at Night Ballroom 1&2
Moderator: Alana Welm, PhD
* NK cell induced dormancy
Ana Luisa Correia, PhD
* Extra cellular matrix and
dormancy
Javier Bravo-Cordero, PhD
* Implications for clinical care
Alexandra Thomas, MD,
FACP
FORUM #2
New Targets and Strategies
for Immunotherapy
Stars at Night Ballroom 3&4
Moderator: Justin Balko, PhD
* Activating a collaborative
innate-adaptive immune
response to control metastasis
Mikala
Egeblad, PhD
* Neutrophil elastase and
anti-tumor effects
Lev Becker, PhD
* Immunosuppressive macrophages
and PARP inhibitor
resistance
Jennifer Guerriero, PhD
3:00 pm - 5:00 pm
EDUCATIONAL SESSION
BLOCK #2A
Digital Health and PROs in
Breast Cancer Research and
Care
Hemisfair Ballroom 1&2
Moderator: Ann H. Partridge,
MD, MPH
* What are PROs and evidence
for benefit?
Shoshana Rosenberg, ScD,
MPH
* How to incorporate PROs
into clinical care
Oluwadamilola " Lola "
Fayanju, MD, MA, MPHS,
FACS
* Where are we going with
digital interventions and
PROs
Ines Vaz Luis, PhD
* Patient Advocate Perspective
Patty Spears, BS
EDUCATIONAL SESSION
BLOCK #2B
Antibody Drug Conjugates:
Future Directions and
Opportunities
Stars at Night Ballroom 1&2
Moderator: Ian E. Krop, MD,
PhD
* Bioengineering and mechanism
of action of ADC
Puja Sapra, PhD
* ADCs in breast oncology:
Present and future
Shanu Modi, MD
* Mechanisms of resistance
Leif Ellisen, MD, PhD
CONTINUED ON PAGE 5 ›
SABCS 2022 Meeting News Preview

Table of Contents for the Digital Edition of SABCS 2022 Meeting News Preview

SABCS 2022 Meeting News Preview - 1
SABCS 2022 Meeting News Preview - 2A
SABCS 2022 Meeting News Preview - 3
SABCS 2022 Meeting News Preview - 4
SABCS 2022 Meeting News Preview - 5
SABCS 2022 Meeting News Preview - 6
SABCS 2022 Meeting News Preview - 7A
SABCS 2022 Meeting News Preview - 8
SABCS 2022 Meeting News Preview - Insert-1
SABCS 2022 Meeting News Preview - Insert-2
SABCS 2022 Meeting News Preview - 9
https://www.nxtbookmedia.com